|
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Utah |
I Care I Cure |
|
Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
I Care I Cure |
|
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma |
University of Virginia, School of Medicine |
I Care I Cure |
|
Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery |
University of Massachusetts Medical School |
I Care I Cure |
|
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma
|
Beckham Research Institute of City of Hope |
I Care I Cure |
|
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute |
I Care I Cure |
|
Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma |
University of Maryland, College Park |
I Care I Cure |
